Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1959 1
1960 1
1962 5
1964 2
1965 4
1966 3
1967 1
1968 2
1969 2
1970 3
1971 1
1972 1
1973 2
1974 4
1975 4
1976 5
1977 7
1978 11
1979 19
1980 6
1981 11
1982 17
1983 15
1984 13
1985 15
1986 20
1987 21
1988 20
1989 24
1990 25
1991 28
1992 26
1993 41
1994 30
1995 45
1996 42
1997 33
1998 40
1999 59
2000 49
2001 51
2002 50
2003 59
2004 62
2005 79
2006 99
2007 121
2008 143
2009 155
2010 158
2011 183
2012 204
2013 226
2014 228
2015 226
2016 207
2017 204
2018 195
2019 210
2020 248
2021 180
Text availability
Article attribute
Article type
Publication date

Search Results

3,551 results
Results by year
Filters applied: . Clear all
Page 1
Biologics switch in psoriasis.
Wang TS, Tsai TF. Wang TS, et al. Among authors: tsai tf. Immunotherapy. 2019 Apr;11(6):531-541. doi: 10.2217/imt-2018-0131. Immunotherapy. 2019. PMID: 31135243 Review.
Burden of atopic dermatitis in Asia.
Tsai TF, Rajagopalan M, Chu CY, Encarnacion L, Gerber RA, Santos-Estrella P, Llamado LJQ, Tallman AM. Tsai TF, et al. J Dermatol. 2019 Oct;46(10):825-834. doi: 10.1111/1346-8138.15048. Epub 2019 Aug 22. J Dermatol. 2019. PMID: 31436343 Review.
Psoriasis and Co-morbidity.
Amin M, Lee EB, Tsai TF, Wu JJ. Amin M, et al. Among authors: tsai tf. Acta Derm Venereol. 2020 Jan 30;100(3):adv00033. doi: 10.2340/00015555-3387. Acta Derm Venereol. 2020. PMID: 31971602 Free article. Review.
A drug safety evaluation of risankizumab for psoriasis.
Huang YW, Tsai TF. Huang YW, et al. Among authors: tsai tf. Expert Opin Drug Saf. 2020 Apr;19(4):395-402. doi: 10.1080/14740338.2020.1736034. Epub 2020 Mar 5. Expert Opin Drug Saf. 2020. PMID: 32100591 Review.
Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): a randomised, double-blind, active-comparator-controlled phase 3 trial.
Reich K, Gooderham M, Thaçi D, Crowley JJ, Ryan C, Krueger JG, Tsai TF, Flack M, Gu Y, Williams DA, Thompson EHZ, Paul C. Reich K, et al. Among authors: tsai tf. Lancet. 2019 Aug 17;394(10198):576-586. doi: 10.1016/S0140-6736(19)30952-3. Epub 2019 Jul 4. Lancet. 2019. PMID: 31280967 Clinical Trial.
3,551 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page